Related Experiment Videos
[Cytomegalovirus infection in HIV]
U Ferone1, C Cerimele, L Isceri
1Istituto di Malattie Infettive, Università degli Studi La Sapienza, Roma.
Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques
|May 1, 1994
Summary
Early ganciclovir treatment for cytomegalovirus (CMV) disease in AIDS patients with asymptomatic retinitis can suppress lesion progression. This intervention appears effective in preventing CMV disease evolution.
Area of Science:
- Infectious Diseases
- Ophthalmology
- Retroviral Infections
Background:
- Cytomegalovirus (CMV) disease is a significant opportunistic infection in patients with Acquired Immunodeficiency Syndrome (AIDS).
- Understanding the characteristics associated with CMV disease development is crucial for timely intervention.
Purpose of the Study:
- To identify key characteristics linked to CMV disease in AIDS patients.
- To evaluate the efficacy of ganciclovir therapy for CMV retinitis, both symptomatic and asymptomatic.
Main Methods:
- Retrospective study of 24 AIDS patients diagnosed with CMV disease.
- Analysis of patient demographics (age, sex), risk factors, and time from HIV seropositivity to CMV disease diagnosis.
- Assessment of ganciclovir treatment outcomes in patients with symptomatic versus asymptomatic retinitis.
Main Results:
- Key characteristics associated with CMV disease development were examined.
- Ganciclovir therapy demonstrated efficacy in patients with both symptomatic and asymptomatic retinitis.
- Early treatment of asymptomatic CMV chorioretinitis suppressed lesion progression.
Conclusions:
- Early intervention with ganciclovir for asymptomatic CMV retinitis is effective.
- Prompt treatment can prevent the progression and evolution of CMV disease in AIDS patients.